|
[1] SHIRATA C,HASEGAWA K,KOKUDO T,et al. Liver resection for hepatocellular carcinoma in patients with renal dysfunction[J]. World J Surg,2018,42(12):4054-4062.
|
|
[2] ABOU-ALFA GK,MEYER T,CHENG AL,et al. Cabozantinib in patients with advanced and progressing hepatocellular carcinoma[J]. N Engl J Med,2018,379(1):54-63.
|
|
[3] GARDINI AC,FOSCHI FG,CONTI F,et al. Immune inflammation indicators and ALBI score to predict occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals[J]. Dig Liver Dis,2018,50(1):50-51.
|
|
[4] WANG M,XI D,NING Q. Virus-induced hepatocellular carcinoma with special emphasis on HBV[J]. Hepatol Int,2017,11(2):171-180.
|
|
[5] GAO Q,WANG K,CHEN K,et al. HBx protein-mediated ATOH1 downregulation suppresses ARID2 expression and promotes hepatocellular carcinoma.[J]. Cancer Sci,2017,108(7):1328-1337.
|
|
[6] SHI T,HUA Q,MA Z,et al. Downregulation of miR-200a-3p induced by hepatitis B virus X(HBx)protein promotes cell proliferation and invasion in HBV-infection-associated hepatocarcinoma[J]. Pathol Res Pract,2017,213(12):1464-1469.
|
|
[7] HUANG CF,HUANG CY,YEH ML,et al. Genetics variants and serum levels of MHC class I chain-related a in predicting hepatocellular carcinoma development in chronic hepatitis C patients post antiviral treatment[J]. Ebiomedicine,2017,15:81-89.
|
|
[8] HUANG CF,WANG SC,YEH ML,et al. Association of serial serum major histocompatibility complex class I chain-related A measurements with hepatocellular carcinoma in chronic hepatitis C patients after viral eradication[J]. J Gastroenterol Hepatol,2019,34(1):249-255.
|
|
[9] SUN D,WANG X,ZHANG H,et al. MMP9 mediates MICA shedding in human osteosarcomas[J]. Cell Biol Int,2011,35(6):569-574.
|
|
[10] HEIMBACH JK,KULIK LM,FINN RS,et al. AASLD guidelines for the treatment of hepatocellular carcinoma[J]. Hepatology,2018,67(1):358-380.
|
|
[11] Cancer Genome Atlas Research Network. Comprehensive and integrative genomic characterization of hepatocellular carcinoma[J]. Cell,2017,169(7):1327-1341. e23.
|
|
[12] QIN G,DANG M,GAO H,et al. Deciphering the proteinprotein interaction network regulating hepatocellular carcinoma metastasis[J]. Biochim Biophys Acta Proteins Proteom,2017,1865(9):1114-1122.
|
|
[13] CHEUNG KS,SETO WK,WONG DK,et al. Relationship between HBsAg,HBcrAg and hepatocellular carcinoma in patients with undetectable HBV DNA under nucleos(t)ide therapy[J]. J Viral Hepat,2017,24(8):654-661.
|
|
[14] WANG X,OISHI N,SHIMAKAMI T,et al. Hepatitis B virus X protein induces hepatic stem cell-like features in hepatocellular carcinoma by activating KDM5B[J]. World J Gastroenterol,2017,23(18):3252-3261.
|
|
[15] YANG Q,LI XP,ZHONG YB,et al. Interferon-αinhibits cell migration and invasion and induces the expression of antiviral proteins in Huh-7 cells transfected with hepatitis B virus X gene-expressing lentivirus[J]. Exp Ther Med,2017,14(6):5924-5930.
|
|
[16] BRABLETZ T,KALLURI R,NIETO MA,et al. EMT in cancer[J]. Nat Rev Cancer,2018,18(2):128-134.
|
|
[17] SABA NF,WANG Y,FU H,et al. Association of cytoplasmic CXCR4 with loss of epithelial marker and activation of ERK1/2and AKT signaling pathways in non-small-cell lung cancer[J]. Clin Lung Cancer,2017,18(3):e203-e210.
|
|
[18] HAI H,TAMORI A,THUY L,et al. Polymorphisms in MICA,but not in DEPDC5,HCP5 or PNPLA3,are associated with chronic hepatitis C-related hepatocellular carcinoma[J]. Sci Rep,2017,7(1):11912.
|
|
[19] ARAI J,GOTO K,STEPHANOU A,et al. Predominance of regorafenib over sorafenib:Restoration of membrane-bound MICA in hepatocellular carcinoma cells[J]. J Gastroenterol Hepatol,2018,33(5):1075-1081.
|
|
[20] CHEN J,XU H,ZHU XX. Abnormal expression levels of sMICA and NKG2D are correlated with poor prognosis in pancreatic cancer[J]. Ther Clin Risk Manag,2016,12:11-18.
|
本站查看
DownLoad: